JP2025023938A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025023938A5 JP2025023938A5 JP2024185776A JP2024185776A JP2025023938A5 JP 2025023938 A5 JP2025023938 A5 JP 2025023938A5 JP 2024185776 A JP2024185776 A JP 2024185776A JP 2024185776 A JP2024185776 A JP 2024185776A JP 2025023938 A5 JP2025023938 A5 JP 2025023938A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- new products
- manufacturing methods
- manufacturing
- methods substantially
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1900529.7 | 2019-01-15 | ||
| GBGB1900529.7A GB201900529D0 (en) | 2019-01-15 | 2019-01-15 | Bicyclic peptide ligands specific for CD38 |
| PCT/GB2020/050073 WO2020148529A1 (en) | 2019-01-15 | 2020-01-15 | Bicyclic peptide ligands specific for cd38 |
| JP2021540842A JP7645801B2 (ja) | 2019-01-15 | 2020-01-15 | Ｃｄ３８に特異的な二環式ペプチドリガンド |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540842A Division JP7645801B2 (ja) | 2019-01-15 | 2020-01-15 | Ｃｄ３８に特異的な二環式ペプチドリガンド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025023938A JP2025023938A (ja) | 2025-02-19 |
| JP2025023938A5 true JP2025023938A5 (enExample) | 2025-03-03 |
Family
ID=65528180
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540842A Active JP7645801B2 (ja) | 2019-01-15 | 2020-01-15 | Ｃｄ３８に特異的な二環式ペプチドリガンド |
| JP2024185776A Pending JP2025023938A (ja) | 2019-01-15 | 2024-10-22 | Ｃｄ３８に特異的な二環式ペプチドリガンド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540842A Active JP7645801B2 (ja) | 2019-01-15 | 2020-01-15 | Ｃｄ３８に特異的な二環式ペプチドリガンド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220064218A1 (enExample) |
| EP (1) | EP3911365A1 (enExample) |
| JP (2) | JP7645801B2 (enExample) |
| CN (1) | CN113543813B (enExample) |
| GB (1) | GB201900529D0 (enExample) |
| WO (1) | WO2020148529A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2708459C2 (ru) | 2014-10-29 | 2019-12-09 | БайсиклРД Лимитед | Бициклические пептидные лиганды, специфичные для мт1-ммр |
| JP7670481B2 (ja) | 2017-08-04 | 2025-04-30 | バイスクルテクス・リミテッド | Ｃｄ１３７に対して特異的な二環式ペプチドリガンド |
| JP2021514953A (ja) | 2018-02-23 | 2021-06-17 | バイスクルテクス・リミテッド | 多量体二環式ペプチドリガンド |
| US11180531B2 (en) | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| GB201820288D0 (en) | 2018-12-13 | 2019-01-30 | Bicycle Tx Ltd | Bicycle peptide ligaands specific for MT1-MMP |
| GB201820325D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for psma |
| GB201820295D0 (en) | 2018-12-13 | 2019-01-30 | Bicyclerd Ltd | Bicyclic peptide ligands specific for MT1-MMP |
| EP3897849A1 (en) | 2018-12-21 | 2021-10-27 | BicycleTx Limited | Bicyclic peptide ligands specific for pd-l1 |
| TWI860386B (zh) | 2019-07-30 | 2024-11-01 | 英商拜西可泰克斯有限公司 | 異質雙環肽複合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1720907B1 (en) | 2004-02-06 | 2015-04-08 | MorphoSys AG | Anti-cd38 human antibodies and uses therefor |
| DK2257624T5 (da) * | 2008-02-05 | 2012-09-10 | Medical Res Council | Fremgangsmåder og sammensætninger |
| US20140274759A1 (en) * | 2013-03-15 | 2014-09-18 | Bicycle Therapeutics Limited | Modification of polypeptides |
| RU2708459C2 (ru) * | 2014-10-29 | 2019-12-09 | БайсиклРД Лимитед | Бициклические пептидные лиганды, специфичные для мт1-ммр |
| EP3288962A1 (en) * | 2015-04-28 | 2018-03-07 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Novel inhibitors of the enzyme activated factor xii (fxiia) |
| GB201600911D0 (en) * | 2016-01-18 | 2016-03-02 | Bicycle Therapeutics Ltd | Stabilized peptide derivatives |
| GB201600903D0 (en) * | 2016-01-18 | 2016-03-02 | Bicycle Therapeutics Ltd | Peptide derivaties |
| US10899798B2 (en) * | 2017-06-26 | 2021-01-26 | Bicyclerd Limited | Bicyclic peptide ligands with detectable moieties and uses thereof |
| GB201810320D0 (en) * | 2018-06-22 | 2018-08-08 | Bicycletx Ltd | Peptide ligands for binding to CD38 |
-
2019
- 2019-01-15 GB GBGB1900529.7A patent/GB201900529D0/en not_active Ceased
-
2020
- 2020-01-15 US US17/422,940 patent/US20220064218A1/en active Pending
- 2020-01-15 WO PCT/GB2020/050073 patent/WO2020148529A1/en not_active Ceased
- 2020-01-15 JP JP2021540842A patent/JP7645801B2/ja active Active
- 2020-01-15 EP EP20701837.5A patent/EP3911365A1/en active Pending
- 2020-01-15 CN CN202080019655.7A patent/CN113543813B/zh active Active
-
2024
- 2024-10-22 JP JP2024185776A patent/JP2025023938A/ja active Pending